Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Jamie153 who wrote (1302513)	6/1/2021 3:44:25 PM
From: Bill	3 Recommendations Recommended By FJB Mick Mørmøny Winfastorlose Read Replies (1) \| Respond to of 1576130

60% plus 40% equals 100%. The "fact checkers" need to go back to 3rd grade.

To: Jamie153 who wrote (1302513)	6/2/2021 1:37:35 AM
From: Winfastorlose	3 Recommendations Recommended By FJB isopatch Mick Mørmøny Read Replies (2) \| Respond to of 1576130

Vaccine researcher: “We made a big mistake … we never knew the spike protein itself was a toxin”… “We thought the spike protein was a great target antigen, we never knew the spike protein itself was a toxin and was a pathogenic protein. So by vaccinating people we are inadvertently inoculating them with a toxin,” Bridle said on the show, which is not easily found in a Google search but went viral on the internet this weekend. Bridle, a vaccine researcher who was awarded a $230,000 government grant last year for research on COVID vaccine development, said that he and a group of international scientists filed a request for information from the Japanese regulatory agency to get access to what’s called the “ biodistribution study.” “It’s the first time ever scientists have been privy to seeing where these messenger RNA [mRNA] vaccines go after vaccination,” said Bridle. “Is it a safe assumption that it stays in the shoulder muscle? The short answer is: absolutely not. It’s very disconcerting.” Vaccine researchers had assumed that novel mRNA COVID vaccines would behave like “traditional” vaccines and the vaccine spike protein — responsible for infection and its most severe symptoms — would remain mostly in the vaccination site at the shoulder muscle. Instead, the Japanese data showed that the infamous spike protein of the coronavirus gets into the blood where it circulates for several days post-vaccination and then accumulated in organs and tissues including the spleen, bone marrow, the liver, adrenal glands, and in “quite high concentrations” in the ovaries. “We have known for a long time that the spike protein is a pathogenic protein. It is a toxin. It can cause damage in our body if it gets into circulation,” Bridle said. “What has been discovered by the scientific community is the spike protein on its own is almost entirely responsible for the damage to the cardiovascular system, if it gets into circulation,” Bridle told listeners. Lab animals injected with purified spike protein into their bloodstream developed cardiovascular problems, and the spike protein was also demonstrated to cross the blood brain barrier and cause damage to the brain. A grave mistake, according to Bridle, was the belief that the spike protein would not escape into the blood circulation. “Now, we have clear-cut evidence that the vaccines that make the cells in our deltoid muscles manufacture this protein — that the vaccine itself, plus the protein — gets into blood circulation,” he said.

To: Jamie153 who wrote (1302513)	6/2/2021 2:12:11 AM
From: Winfastorlose	3 Recommendations Recommended By FJB isopatch Mick Mørmøny Read Replies (1) \| Respond to of 1576130

It is becoming evident that the vaccine doesn't necessarily protect you from getting Covid or from passing it to others. . Oracle VP Joel Kallman dies of Covid shortly after getting vaxxed… Timeline: Kallman vaxxed on Mar. 26th, final Tweet on March 29th, died May 25th… Worst “vaccine” ever? Study finds fully vaccinated people still pass on Covid virus variants… Eight from Yankees test positive for Covid in post-vaccine breakthrough cases